12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
During Friday's after-market session, several health care stocks experienced significant movement. Bionomics (BNOX), Oragenics (OGEN), and Syndax Pharmaceuticals (SNDX) were among the gainers, with increases of 24.0%, 21.54%, and 15.15% respectively. On the other hand, Comera Life Sciences (CMRA), TC BioPharm (TCBP), and NeuBase Therapeutics (NBSE) were among the losers, with decreases of 12.3%, 6.98%, and 5.73% respectively.
September 29, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionomics stock increased by 24.0% to $3.46 during Friday's after-market session.
The significant increase in Bionomics' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Oragenics shares increased by 21.54% to $3.61 during Friday's after-market session.
The significant increase in Oragenics' share price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Syndax Pharmaceuticals stock moved upwards by 15.15% to $16.72 during Friday's after-market session.
The significant increase in Syndax Pharmaceuticals' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Comera Life Sciences stock decreased by 12.3% to $0.28 during Friday's after-market session.
The significant decrease in Comera Life Sciences' stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
NeuBase Therapeutics shares decreased by 5.73% to $0.82 during Friday's after-market session.
The significant decrease in NeuBase Therapeutics' share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
TC BioPharm stock fell 6.98% to $0.4 during Friday's after-market session.
The significant decrease in TC BioPharm's stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100